Literature DB >> 1416817

Pulmonary disposition of antimicrobial agents: in vivo observations and clinical relevance.

D R Baldwin1, D Honeybourne, R Wise.   

Abstract

Mesh:

Substances:

Year:  1992        PMID: 1416817      PMCID: PMC190300          DOI: 10.1128/AAC.36.6.1176

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  47 in total

Review 1.  Pulmonary disposition of antimicrobial agents: methodological considerations.

Authors:  D R Baldwin; D Honeybourne; R Wise
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

2.  TREATMENT OF CHRONIC BRONCHITIS WITH AMPICILLIN: SOME PHARMACOLOGICAL OBSERVATION.

Authors:  J R MAY; D M DELVES
Journal:  Lancet       Date:  1965-05-01       Impact factor: 79.321

3.  The penetration of cefpirome into the potential sites of pulmonary infection.

Authors:  D R Baldwin; S R Maxwell; D Honeybourne; J M Andrews; J P Ashby; R Wise
Journal:  J Antimicrob Chemother       Date:  1991-07       Impact factor: 5.790

4.  Concentrations of oral lomefloxacin in serum and bronchial mucosa.

Authors:  D R Baldwin; D Honeybourne; J M Andrews; J P Ashby; R Wise
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

5.  Concentrations of cefixime in bronchial mucosa and sputum after three oral multiple dose regimens.

Authors:  D R Baldwin; J M Andrews; J P Ashby; R Wise; D Honeybourne
Journal:  Thorax       Date:  1990-05       Impact factor: 9.139

Review 6.  Pharmacokinetics of antibiotics in the lungs.

Authors:  Y Valcke; R Pauwels; M Van der Straeten
Journal:  Eur Respir J       Date:  1990-06       Impact factor: 16.671

7.  Methods for the clinical evaluation of antibiotics in urinary tract infections.

Authors:  G G Jackson
Journal:  Scand J Infect Dis Suppl       Date:  1978

8.  Plasma and sputum erythromycin concentrations in chronic bronchitis.

Authors:  G E Marlin; P R Davis; J Rutland; N Berend
Journal:  Thorax       Date:  1980-06       Impact factor: 9.139

9.  Sputum and serum levels of amoxycillin in chronic bronchial infections.

Authors:  A Ingold
Journal:  Br J Dis Chest       Date:  1975-07

Review 10.  Doxycycline in serum and bronchial secretions.

Authors:  B J Hartnett; G E Marlin
Journal:  Thorax       Date:  1976-04       Impact factor: 9.139

View more
  39 in total

Review 1.  Clinical role of protein binding of quinolones.

Authors:  Eugénie Bergogne-Bérézin
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 2.  Lung microdialysis--a powerful tool for the determination of exogenous and endogenous compounds in the lower respiratory tract (mini-review).

Authors:  Markus Zeitlinger; Markus Müller; Christian Joukhadar
Journal:  AAPS J       Date:  2005-10-22       Impact factor: 4.009

3.  Comparison of the pharmacodynamics of biapenem in bronchial epithelial lining fluid in healthy volunteers given half-hour and three-hour intravenous infusions.

Authors:  Eiki Kikuchi; Junko Kikuchi; Yasuyuki Nasuhara; Satoshi Oizumi; Akitoshi Ishizaka; Masaharu Nishimura
Journal:  Antimicrob Agents Chemother       Date:  2009-04-20       Impact factor: 5.191

Review 4.  Lung infections. 3. Pseudomonas aeruginosa and other related species.

Authors:  R Wilson; R B Dowling
Journal:  Thorax       Date:  1998-03       Impact factor: 9.139

Review 5.  Penetration of anti-infective agents into pulmonary epithelial lining fluid: focus on antibacterial agents.

Authors:  Keith A Rodvold; Jomy M George; Liz Yoo
Journal:  Clin Pharmacokinet       Date:  2011-10       Impact factor: 6.447

6.  Effects of AIDS and gender on steady-state plasma and intrapulmonary ethionamide concentrations.

Authors:  J E Conte; J A Golden; M McQuitty; J Kipps; E T Lin; E Zurlinden
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

7.  Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers.

Authors:  K A Rodvold; M H Gotfried; L H Danziger; R J Servi
Journal:  Antimicrob Agents Chemother       Date:  1997-06       Impact factor: 5.191

Review 8.  Pharmacodynamics and pharmacokinetics of spiramycin and their clinical significance.

Authors:  I Brook
Journal:  Clin Pharmacokinet       Date:  1998-04       Impact factor: 6.447

9.  Effects of gender, AIDS, and acetylator status on intrapulmonary concentrations of isoniazid.

Authors:  John E Conte; Jeffrey A Golden; Mari McQuitty; Juliana Kipps; Sheila Duncan; Elaine McKenna; Elisabeth Zurlinden
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

Review 10.  Pharmacokinetic and Pharmacodynamic Principles of Anti-infective Dosing.

Authors:  Nikolas J Onufrak; Alan Forrest; Daniel Gonzalez
Journal:  Clin Ther       Date:  2016-07-20       Impact factor: 3.393

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.